Digital pathology technology set to transform medical diagnosis

FHS
July 21, 2023
2:59 am

Patients will receive faster and more accurate pathology results following a decade-long research project that is set to transform medical diagnosis.

It’s time for the FDA to halt Cassava Sciences’ Alzheimer’s clinical trials

The Food and Drug Administration should halt Cassava Sciences’ ongoing clinical trials in Alzheimer’s disease. That, and other thoughts on the fallout from the City

October 17, 2023

PBMs aren’t opening access to lower-cost biosimilars. Reform is needed now

The Federal Trade Commission presents on Thursday its interim staff report, “Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies.” It

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Digital pathology technology set to transform medical diagnosis

It’s time for the FDA to halt Cassava Sciences’ Alzheimer’s clinical trials

PBMs aren’t opening access to lower-cost biosimilars. Reform is needed now

New research links social factors to cardiovascular risk in Asian American adults

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe